Health Decisions
Health Decisions is a Durham, NC-based CRO founded in 1989 that delivers clinical research, regulatory consulting, and clinical technology services to pharmaceutical, biotech, MedTech, and advanced therapy developers globally.
- Company typePrivate
- Founded1989
- HeadquartersDurham, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Health Decisions does
Health Decisions is a privately-held, Durham, North Carolina-headquartered contract research organization (CRO) founded in 1989. Per the firmographic profile, the company positions itself as the 'CRO of choice for forward-looking biopharma & medical device companies' focused on the modernization of clinical development. The organization operates with 51–100 employees and maintains a web presence at healthdec.com.
The aggregated service and product data describes a full-service clinical development stack: comprehensive clinical research and development (study design, start-up, medical affairs, biostatistics & data management, central monitoring, clinical monitoring & site management, project & risk management, safety & pharmacovigilance, quality & compliance, medical writing, global records/TMF management); functional service provision (FSP) for in-sourced sponsor functions; program & regulatory strategy consulting (regulatory affairs, submissions & publishing, market access, TMF remediation); translational research and model-informed drug development (MIDD) including CMC, nonclinical toxicology, clinical pharmacology, and pharmacometrics; and a technology layer comprising study management platforms, RBQM (Risk-Based Quality Management), eClinical Solutions, and virtual/decentralized clinical trial services. Therapeutic depth spans oncology & hematology, neuroscience, rare disease, cell & gene therapy, immunology, dermatology, women's health, analgesia, pediatrics, 505(b)(2) pathway, and MedTech.
The business model is professional services and managed services revenue, delivered through custom, quote-based, multi-year contracts with pharmaceutical, biotech, MedTech, and advanced therapy sponsors. Go-to-market is enterprise field sales, supported by a content-marketing engine (Premier Perspectives blog, Resource Center, webinars, virtual events) for top- and mid-funnel demand generation. Pricing is not publicly disclosed. The aggregated source material references Premier Research International LLC (premier-research.com) as the underlying legal entity and digital property across the product, customer segment, and technology fields, suggesting a corporate affiliation, acquisition, or data aggregation overlap between Health Decisions and Premier Research that the inputs do not explicitly reconcile.
Health Decisions firmographics
Firmographics- Name
- Health Decisions
- Legal name
- Premier Research International LLC
- Website
- https://healthdec.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Health Decisions is a Durham, NC-based CRO founded in 1989 that delivers clinical research, regulatory consulting, and clinical technology services to pharmaceutical, biotech, MedTech, and advanced therapy developers globally.
- Ownership category
- akta.pro rank
Health Decisions industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
Keywords
Where Health Decisions is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Markets served
Health Decisions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Research & Development Services: Full-service clinical research including study design, site management, monitoring, data management, and regulatory submissions for pharmaceutical and biotech clients
- Functional Service (FSP): Flexible staffing solutions providing dedicated functional services to sponsors, allowing them to scale resources as needed
- Consulting Services: Regulatory strategy, program management, and translational research consulting including CMC, toxicology, and clinical pharmacology
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Health Decisions product offering
Product offeringCore offering
Health Decisions is a contract research organization (CRO) providing clinical research and development services for biopharma and medical device companies. The company offers full-service clinical trial execution, observational and post-marketing studies, functional service provision (FSP), regulatory and program strategy consulting, translational research and model-informed drug development, and technology-enabled study management, RBQM, eClinical, and decentralized/virtual trial capabilities.
Product overview
Premier Research operates as a global full-service Contract Research Organization (CRO) offering an integrated platform of clinical research and development services. The portfolio includes three core pillars: (1) Clinical Research & Development encompassing Full Service Clinical Research, Observational/Registry/Post-Marketing Studies, and Functional Service (FSP); (2) Consulting services covering Program & Regulatory Strategy, Translational Research & MIDD, and Program Management; and (3) Technology platforms including Study Management, RBQM (Risk-Based Quality Management), and eClinical Solutions. Additional offerings include Virtual Clinical Trial Services for decentralized trials. The company also provides deep therapeutic expertise across Oncology & Hematology, Neuroscience, Rare Disease, Cell & Gene Therapy, Immunology, Dermatology, Women's Health, Analgesia, Pediatrics, 505(b)(2) Pathway, and MedTech.
Differentiator
Problem solved
Functional benefit
Products and services
- Full Service Clinical Research
Companies that use Health Decisions
Customer profileSegments3 records
Ideal customer profiles3 records
Health Decisions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Health Decisions partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights6 records
Health Decisions competitors and assessment
Company assessmentBroad incumbents
- ICON plc: Top-three global CRO offering full-service clinical development, FSP, and consulting across all major therapeutic areas, including rare disease and CNS — directly comparable to Health Decisions' core offerings.
- Fortrea (formerly Labcorp Drug Development): Large full-service CRO spun out of Labcorp covering Phase I–IV clinical services, FSP, and consulting — a direct scale competitor in the same enterprise CRO buyer pool.
- IQVIA: Largest global CRO and life sciences services platform. Broad incumbent competing across all of Health Decisions' therapeutic areas with deeper geographic reach, technology scale, and data assets.
- Syneos Health: Global biopharma solutions organization combining full-service CRO with commercial services. Competes for the same biotech and pharma sponsor budgets across clinical development and post-approval.
- Parexel International: Privately held global CRO (backed by EQT and GIC) with deep expertise in oncology, rare disease, and CGT — one of the most direct therapeutic-area comparables to Health Decisions.
- Medpace Holdings: Mid-to-large full-service CRO with strong therapeutic-area franchises (oncology, rare disease, CNS) and an integrated technology platform — closely mirrors Health Decisions' mid-sized, specialty-focused positioning at a larger scale.
- Charles River Laboratories: Broader life sciences services platform with significant CRO and preclinical (including toxicology) capabilities. Overlaps with Health Decisions' Translational Research & MIDD offering and global clinical services footprint.
Direct peers
- Premier Research: Closest operational peer — the bulk of Health Decisions' product, technology, and customer segmentation data appears to originate from Premier Research, suggesting a parent or successor entity. Directly comparable full-service CRO with overlapping therapeutic footprint (oncology, rare disease, CGT, neuroscience).
- Worldwide Clinical Trials: Mid-sized global CRO focused on complex therapeutic areas including neuroscience, rare disease, and oncology. Closest peer in scale and specialty positioning to Health Decisions.
- CTI Clinical Trial & Consulting Services: Mid-sized CRO with strong specialty therapeutic focus (rare disease, oncology, cell therapy) — comparable in scale, therapeutic mix, and engagement model to Health Decisions.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Health Decisions social profiles
Digital presenceHealth Decisions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Health Decisions leadership team
Management profileNumber of profiles
Profiles3 records
Health Decisions funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Health Decisions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Health Decisions
What does Health Decisions do?
Health Decisions is a contract research organization (CRO) providing clinical research and development services for biopharma and medical device companies. The company offers full-service clinical trial execution, observational and post-marketing studies, functional service provision (FSP), regulatory and program strategy consulting, translational research and model-informed drug development, and technology-enabled study management, RBQM, eClinical, and decentralized/virtual trial capabilities.
Is Health Decisions a public or private company?
Health Decisions is a private company. It is classified as venture growth investor backed and is currently operating.
When was Health Decisions founded?
Health Decisions was founded in 1989. It employs 51 to 100 people.
Where is Health Decisions based?
Health Decisions is headquartered in Durham, United States, in the North America region.
How does Health Decisions make money?
Three revenue lines are on record. Clinical Research & Development Services are the primary driver. The others are functional Service (FSP) and consulting Services.
Who are Health Decisions's main competitors?
Broad incumbents on record are ICON plc, Fortrea (formerly Labcorp Drug Development), IQVIA, Syneos Health, Parexel International, Medpace Holdings and Charles River Laboratories. Direct peers are Premier Research, Worldwide Clinical Trials and CTI Clinical Trial & Consulting Services.
Does Health Decisions have an API?
No public API is recorded for Health Decisions.
What industry is Health Decisions in?
Health Decisions's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.